These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3776665)

  • 1. Is there a relationship between response to total sleep deprivation and efficacy of clomipramine treatment in depressed patients?
    Höchli D; Riemann D; Zulley J; Berger M
    Acta Psychiatr Scand; 1986 Aug; 74(2):190-2. PubMed ID: 3776665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to total sleep deprivation and clomipramine in endogenous depression.
    Elsenga S; Van den Hoofdakker RH
    J Psychiatr Res; 1987; 21(2):151-61. PubMed ID: 3585805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of total sleep deprivation and subsequent treatment with clomipramine on depressive symptoms and sleep electroencephalography in patients with a major depressive disorder.
    Riemann D; Berger M
    Acta Psychiatr Scand; 1990 Jan; 81(1):24-31. PubMed ID: 2330825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial REM sleep suppression by clomipramine: a prognostic tool for treatment response in patients with a major depressive disorder.
    Höchli D; Riemann D; Zulley J; Berger M
    Biol Psychiatry; 1986 Oct; 21(12):1217-20. PubMed ID: 3756267
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of clomipramine and doxepin in neurotic depression.
    Kornhaber A; Horwitz IM
    J Clin Psychiatry; 1984 Aug; 45(8):337-41. PubMed ID: 6378895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial.
    Smeraldi E; Benedetti F; Barbini B; Campori E; Colombo C
    Neuropsychopharmacology; 1999 Apr; 20(4):380-5. PubMed ID: 10088139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
    Leinonen E; Lepola U; Koponen H; Mehtonen OP; Rimon R
    Acta Psychiatr Scand; 1997 Dec; 96(6):497-504. PubMed ID: 9421348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics.
    Magni G; Garreau M; Orofiamma B; Palminteri R
    Neuropsychobiology; 1989; 20(3):126-31. PubMed ID: 2668780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body core temperature and depression during total sleep deprivation in depressives.
    Elsenga S; Van den Hoofdakker RH
    Biol Psychiatry; 1988 Sep; 24(5):531-40. PubMed ID: 3167142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites: prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data.
    Noguchi T; Shimoda K; Takahashi S
    J Affect Disord; 1993 Dec; 29(4):267-79. PubMed ID: 8126313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of clomipramine infusion on sleep in depressed patients.
    Klein E; Hefez A; Lavie P
    Neuropsychobiology; 1984; 11(2):85-8. PubMed ID: 6483165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total and partial sleep deprivation in clomipramine-treated endogenous depressives.
    Elsenga S; Beersma D; Van den Hoofdakker RH
    J Psychiatr Res; 1990; 24(2):111-9. PubMed ID: 2213635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined chlorimipramine and maprotiline therapy in therapy-resistant depressions].
    Soucek K
    Act Nerv Super (Praha); 1982 May; 24(2):88-9. PubMed ID: 7102229
    [No Abstract]   [Full Text] [Related]  

  • 14. Amineptine in the management of the depressive syndromes.
    Scarzella L; Scarzella R; Mailland F; Bergamasco B
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):429-39. PubMed ID: 4070645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sleep deprivation as a predictor of treatment response to antidepressant medication.
    Fähndrich E
    Acta Psychiatr Scand; 1983 Nov; 68(5):341-4. PubMed ID: 6650211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects of sleep deprivation and clomipramine in endogenous depression.
    Elsenga S; van den Hoofdakker RH
    J Psychiatr Res; 1982-1983; 17(4):361-74. PubMed ID: 7187779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
    Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
    Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous pulse loading of clomipramine in adolescents with depression.
    Sallee FR; Pollock BG; Perel JM; Ryan ND; Stiller RL
    Psychopharmacol Bull; 1989; 25(1):114-8. PubMed ID: 2772110
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized, double-blind, parallel-group comparison of venlafaxine and clomipramine in outpatients with major depression.
    Samuelian JC; Hackett D
    J Psychopharmacol; 1998; 12(3):273-8. PubMed ID: 10958254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial.
    Sallee FR; Vrindavanam NS; Deas-Nesmith D; Carson SW; Sethuraman G
    Am J Psychiatry; 1997 May; 154(5):668-73. PubMed ID: 9137123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.